Cargando…
Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer
The estrogen receptor α (ERα) corresponds to a large platform in charge of the recruitment of a panel of molecules, including steroids and related heterocyclic derivatives, oligonucleotides, peptides and proteins. Its 295–311 region is particularly targeted by post-translational modifications, sugge...
Autores principales: | Kampa, Marilena, Lappano, Rosamaria, Grande, Fedora, Rizzuti, Bruno, Maggiolini, Marcello, Castanas, Elias, Jacquot, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954065/ https://www.ncbi.nlm.nih.gov/pubmed/36831322 http://dx.doi.org/10.3390/cells12040653 |
Ejemplares similares
-
The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells
por: Lappano, Rosamaria, et al.
Publicado: (2019) -
Computational Approaches for the Discovery of GPER Targeting Compounds
por: Grande, Fedora, et al.
Publicado: (2020) -
Interaction of the Anti-Proliferative GPER Inverse Agonist ERα17p with the Breast Cancer Cell Plasma Membrane: From Biophysics to Biology
por: Trichet, Michaël, et al.
Publicado: (2020) -
GPER Function in Breast Cancer: An Overview
por: Lappano, Rosamaria, et al.
Publicado: (2014) -
AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs)
por: Cirillo, Francesca, et al.
Publicado: (2019)